MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
7.73
+0.45 (6.16%)
At close: Jul 10, 2025, 4:00 PM
7.80
+0.07 (0.91%)
After-hours: Jul 10, 2025, 4:22 PM EDT

MiNK Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
31283788149-
Upgrade
Market Cap Growth
8.73%-25.23%-58.11%-40.99%--
Upgrade
Enterprise Value
33263164214-
Upgrade
Last Close Price
7.736.9710.7026.1044.60-
Upgrade
PB Ratio
--1.41-2.05-219.746.29-
Upgrade
P/TBV Ratio
----6.29-
Upgrade
Debt / Equity Ratio
-0.23-0.25----0.81
Upgrade
Quick Ratio
0.270.660.301.552.360.21
Upgrade
Current Ratio
0.300.720.321.612.410.29
Upgrade
Return on Equity (ROE)
----239.50%--
Upgrade
Return on Assets (ROA)
-111.89%-137.35%-110.10%-62.69%-51.92%-230.14%
Upgrade
Return on Capital (ROIC)
----165.50%-169.44%-
Upgrade
Earnings Yield
-31.61%-39.05%-60.80%-31.74%-20.22%-
Upgrade
FCF Yield
-27.12%-34.60%-42.87%-21.68%-8.75%-
Upgrade
Buyback Yield / Dilution
-12.90%-9.82%-2.04%-29.38%-7.95%-0.21%
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q